Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
BPC-157 is supplied as a lyophilised powder for in-vitro laboratory research only, not for human or veterinary use
BPC-157 was first isolated from body protection compound (BPC), which is found in the gastric juices and is part of the digestive process [1]
For example, a child might get 100 mcg at first, then 30-50 mcg every 2-3 weeks
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
If youre training or competing under anti-doping governance, also read BPC-157 TB-500 For Athletes: Performance & WADA Considerations
Synthetic peptide compound supplied for scientific research
US$ 26.70
US$ 24.01
US$ 20.93
US$ 29.42
US$ 22.34
US$ 21.57
US$ 21.82
US$ 25.98
US$ 20.53
US$ 29.51
